Sponsor:
Keryx Biopharmaceuticals
Code:
NCT04523727
Conditions
Hyperphosphatemia Related to Chronic Kidney Disease
Eligibility Criteria
Sex: All
Age: 6 - 16
Healthy Volunteers: Not accepted
Interventions
ferric citrate
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Keryx Biopharmaceuticals on 2025-04-16.